Return to study ST002800 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

SelectMetabolite Name Metabolite Id Refmet Name Ret. Index Quant. m/z Analysis Display
14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid ME725679 14-HDoHE 11.7-Reversed phase UNSPECIFIED ION MODE
16(17)-epoxy-4,7,10,13,19-docosapentaenoic acid ME725699 16(17)-EpDPE 13.04-Reversed phase UNSPECIFIED ION MODE
17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid ME725678 17-HDoHE 11.39-Reversed phase UNSPECIFIED ION MODE
18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-penta... ME725698 19(20)-EpDPE 12.65-Reversed phase UNSPECIFIED ION MODE
19,20-dihydroxydocosa-4,7,10,13,16-pentaenoic acid ME725659 19,20-DiHDPE 8.66-Reversed phase UNSPECIFIED ION MODE
4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid ME725680 4-HDoHE 13.02-Reversed phase UNSPECIFIED ION MODE
Resolvin D1 ME725646 Resolvin D1 5.37-Reversed phase UNSPECIFIED ION MODE


  logo